DL
Therapeutic Areas
Aptamer Group Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Alzheimer's Disease Diagnostic Reagents | Alzheimer's Disease Biomarker Detection | Development |
| Targeted siRNA Delivery (AstraZeneca Collab) | siRNA Delivery | Discovery/Development |
| Consumer Cosmetic Innovation (Unilever) | Cosmetic Applications | Development |
Leadership Team at Aptamer Group
DA
Dr. Adam Hargreaves
Non-Executive Chair
DA
Dr. Arron Tolley
Chief Executive Officer
DD
Dr. David Bunka
Chief Scientific Officer
AR
Andrew Rapson
Chief Financial Officer and Company Secretary
TS
Tim Sykes
Non-Executive Director
PP
Prof. Paul Townsend
Scientific Advisory Board
DS
Dr. Shozo Fujita
Scientific Advisory Board
DP
Dr. Paloma Giangrande
Scientific Advisory Board